Table 1.
Patient | PxD | Sex | AaO (years) | Inducer | Dystonia/chorea | Duration | Frequency | Localisation | EEG | Migraine | Medication | PRRT2 mutation | Other genes tested |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fam. 1, II-2 | PKD | F | 14 | Movement change | D+C | 7–30 s | Daily | Left sided | N/A | – | None | c.649dupC p.R217PfsX7 | |
Fam. 1, II-3 | PKD | M | 15 | Movement change | D+C | 10 s | 10× per day | Left sided | N/A | – | CBZ: good effect | c.649dupC p.R217PfsX7 | GLUT1 |
Fam. 2, IV-2 | PKD | M | 8 | Sudden movement | D | 5–15 s | 1–2× per day | Left sided | N/A | – | CBZ: good effect | None | |
Fam. 2, III-1 | PKD | F | 10 | Sudden movement | D | 10–15 s | Weekly | Right sided | N/A | – | DPhT: moderate effect | None | |
Fam. 2, II-4 | PKD | M | 10 | Sudden movement | D | 10 s | N/A | Right arm | N/A | – | None | None | |
Fam. 3, III-1 | PKD | M | 15 | Sudden movement | D | 10 s | Daily | Left leg | Epilepsy | – | CBZ: good effect | c.649C>T p.R217X | GLUT1 |
Fam. 3, II-4 | PKD | M | 15 | Sudden movement | D | 10–15 s | 3× per week | Left sided | Normal | – | None | c.649C>T p.R217X | |
1, Sporadic | PKD | F | 3 | Playing | D | Minutes | Daily | Right sided | Normal | – | None | No DNA | |
2, Sporadic | PKD | F | 0 | Movement change | D+C | 1.5 min | Several per day | Generalized | Normal | – | None | c.3698T>C in 3′UTR | GLUT1 |
3, Sporadic | PKD | F | 51 | Walking | C | 1 s | 2–10× per day | Both legs | Normal | – | CBZ: good effect | None | GLUT1, MR-1 |
4, Sporadic | PKD | M | 13 | Sudden movement | D | 10 s | 1–2× per day | Right sided | N/A | – | CBZ: good effect | c.649delC p.R217PfsX12 | |
5, Sporadic | PKD | M | 14 | Start of movement | D+C | 15 s | 10× per day | Alternating sides | N/A | – | CBZ: good effect | None | GLUT1, MR-1 |
6, Sporadic | PKD | M | 11 | Movement change | D | 10 s –1 min | 1–2× per day | Generalized | N/A | – | CBZ: good effect | c.649dupC p.R217PfsX7 | |
7, Sporadic | PKD | F | 29 | Small changes of movement | C | Seconds–minutes | Several per day | Left arm | Non-epileptiform PT abnormalities | Yes | TBZ: moderate effect | None | GLUT1, MR-1 |
8, Sporadic | PKD | M | 12 | Sudden movement | D | 10–20 s | 5× per day | Right sided | N/A | – | None | None | GLUT1, MR-1 |
9, Sporadic | PKD | M | 6 | N/A | D | <1 min | Daily | Generalized | Normal | Yes | DPK: good effect | No DNA | |
10, Sporadic | PNKD | F | 0 | No clear inducers | D+C | Minutes | N/A | Generalized | Normal | Yes | CBZ, BDZ, DPK, DPhT: moderate effect | None | MR-1 |
11, Sporadic | PNKD | F | 0 | Physical exercise, cold | D | Several hours | Daily–weekly | Generalized | Suspect for epilepsy | – | BDZs, unknown effect | None | MR-1 |
12, Sporadic | PNKD | F | 9 | Fatigue | D | Minutes to hours | Several a month | Right sided | N/A | Yes | DPK, lot of side effects | None | MR-1 |
13, Sporadic | PNKD | M | 10 | No clear inducers | D | 30 min | Daily | Right sided | Normal | – | Anti-PD medication, CBZ, BDZ: no effect | None | MR-1 |
14, Sporadic | PED | F | 16 | Prolonged exercise | D | Up to 3 h | 7× per quarter | Right arm | PED-like | – | Clobazam | None | GLUT1, MR-1 |
AaO age at onset, PT pariotemporal, CBZ carbamazepine, TBZ tetrabenazide, DPhT diphantoine, DPK depakine, PD Parkinsons disease